Advertisement

Topics

Locus Biosciences Closes $19 Million Series A Led by ARTIS Ventures for CRISPR-Cas3 Antimicrobials

08:30 EST 14 Nov 2017 | BioMedReports - Blog

RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2017/PRNewswire/ -- Locus Biosciences Inc., an emerging biotechnology company focused on the discovery and development of a

Read more...

Original Article: Locus Biosciences Closes $19 Million Series A Led by ARTIS Ventures for CRISPR-Cas3 Antimicrobials

NEXT ARTICLE

More From BioPortfolio on "Locus Biosciences Closes $19 Million Series A Led by ARTIS Ventures for CRISPR-Cas3 Antimicrobials"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...